Brief: Opsens Signs Definitive Agreement For Its Acquisition By Haemonetics
10/10/2023 11:16
Oct 10 (Reuters) - Haemonetics Corp HAE.N :
* OPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY
HAEMONETICS
* OPSENS INC - OPSENS' SHAREHOLDERS RECEIVE SUBSTANTIAL
PREMIUM TO
MARKET PRICE. HAEMONETICS' OFFER OF $2.90 PER SHARE IN CASH
* OPSENS INC - TRANSACTION VALUES OPSENS AT APPROXIMATELY
$345
MILLION, ON A FULLY DILUTED EQUITY BASIS
Source text for Eikon: ID:nCNWC19STa
Further company coverage: HAE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Haemonetics
See all newsBrief: Haemonetics Announces FDA Approval Of Perqseal® Elite Vascular Closure System
Haemonetics says FDA clears vascular closure device
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Haemonetics surges as CSL plans to move all US plasma centers to its devices